Anti-PPIL3 monoclonal antibody

Pre-made anti-PPIL3 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to PPIL3/PPIL3 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP1435-Ab-1/ GM-Tg-hg-IP1435-Ab-2Anti-Human PPIL3 monoclonal antibodyHuman
GM-Tg-rg-IP1435-Ab-1/ GM-Tg-rg-IP1435-Ab-2Anti-Rat PPIL3 monoclonal antibodyRat
GM-Tg-mg-IP1435-Ab-1/ GM-Tg-mg-IP1435-Ab-2Anti-Mouse PPIL3 monoclonal antibodyMouse
GM-Tg-cynog-IP1435-Ab-1/ GM-Tg-cynog-IP1435-Ab-2Anti-Cynomolgus/ Rhesus macaque PPIL3 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP1435-Ab-1/ GM-Tg-felg-IP1435-Ab-2Anti-Feline PPIL3 monoclonal antibodyFeline
GM-Tg-cang-IP1435-Ab-1/ GM-Tg-cang-IP1435-Ab-2Anti-Canine PPIL3 monoclonal antibodyCanine
GM-Tg-bovg-IP1435-Ab-1/ GM-Tg-bovg-IP1435-Ab-2Anti-Bovine PPIL3 monoclonal antibodyBovine
GM-Tg-equg-IP1435-Ab-1/ GM-Tg-equg-IP1435-Ab-2Anti-Equine PPIL3 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP1435-Ab-1/ GM-Tg-hg-IP1435-Ab-2; GM-Tg-rg-IP1435-Ab-1/ GM-Tg-rg-IP1435-Ab-2;
GM-Tg-mg-IP1435-Ab-1/ GM-Tg-mg-IP1435-Ab-2; GM-Tg-cynog-IP1435-Ab-1/ GM-Tg-cynog-IP1435-Ab-2;
GM-Tg-felg-IP1435-Ab-1/ GM-Tg-felg-IP1435-Ab-2; GM-Tg-cang-IP1435-Ab-1/ GM-Tg-cang-IP1435-Ab-2;
GM-Tg-bovg-IP1435-Ab-1/ GM-Tg-bovg-IP1435-Ab-2; GM-Tg-equg-IP1435-Ab-1/ GM-Tg-equg-IP1435-Ab-2
Products NameAnti-PPIL3 monoclonal antibody
Formatmab
Target NamePPIL3
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-PPIL3 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP1435-Ag-1Recombinant multi-species PPIL3/ CYPJ protein
    ORF Viral VectorpGMLP004832human PPIL3 Lentivirus plasmid
    ORF Viral VectorvGMLP004832human PPIL3 Lentivirus particle
    ORF Viral VectorpGMLPm002378mouse Ppil3 Lentivirus plasmid
    ORF Viral VectorvGMLPm002378mouse Ppil3 Lentivirus particle


    Target information

    Target IDGM-IP1435
    Target NamePPIL3
    Gene ID53938,70225,301432,700456,607430,101092630,615703,100067857
    Gene Symbol and Synonyms2310076N22Rik,2510026K04Rik,Cyp10l,CYPJ,PPIL3
    Uniprot AccessionQ9H2H8,Q812D3
    Uniprot Entry NamePPIL3_HUMAN,PPIL3_RAT
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000240344
    Target ClassificationN/A

    The target: PPIL3, gene name: PPIL3, also named as CYPJ. This gene encodes a member of the cyclophilin family. Cyclophilins catalyze the cis-trans isomerization of peptidylprolyl imide bonds in oligopeptides. They have been proposed to act either as catalysts or as molecular chaperones in protein-folding events. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Sep 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.